Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
ACS Medicinal Chemistry Letters|May 20, 2026
Effect of Stereochemistry on the Antiplasmodial Activity and Metabolomic Profile of Novel Tadalafil AnaloguesEsraa A Elhalawaty, Howida A Alseedy, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
Dalton Transactions (Cambridge, England : 2003)|January 7, 2015
Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexesMuneebah Adams, Carmen de Kock, Peter J Smith, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)-H-HydroxylationAlexander Berger, Talea Knak, Anna-Lene Kiffe-Delf, et al.
ACS Infectious Diseases|March 6, 2021
Benzimidazole Derivatives Are Potent against Multiple Life Cycle Stages of <i>Plasmodium falciparum</i> Malaria ParasitesMeta Leshabane, Godwin Akpeko Dziwornu, Dina Coertzen, et al.
Journal of Medicinal Chemistry|June 12, 2018
Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of MalariaNishanth Kandepedu, Diego Gonzàlez Cabrera, Srinivas Eedubilli, et al.
Journal of Medicinal Chemistry|September 1, 2015
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidinesDiego Gonzàlez Cabrera, Frederic Douelle, Claire Le Manach, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2024
Characterization of antimalarial activity of artemisinin-based hybrid drugsHelenita Costa Quadros, Lars Herrmann, Jeanne Manaranche, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
hERG, <i>Plasmodium</i> Life Cycle, and Cross Resistance Profiling of New Azabenzimidazole Analogues of AstemizoleDickson Mambwe, Dina Coertzen, Meta Leshabane, et al.
Journal of Medicinal Chemistry|April 12, 2021
Antimalarial Benzimidazole Derivatives Incorporating Phenolic Mannich Base Side Chains Inhibit Microtubule and Hemozoin Formation: Structure-Activity Relationship and <i>In Vivo</i> Oral Efficacy StudiesGodwin Akpeko Dziwornu, Dina Coertzen, Meta Leshabane, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
ACS Medicinal Chemistry Letters|May 20, 2026
Effect of Stereochemistry on the Antiplasmodial Activity and Metabolomic Profile of Novel Tadalafil AnaloguesEsraa A Elhalawaty, Howida A Alseedy, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
Dalton Transactions (Cambridge, England : 2003)|January 7, 2015
Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexesMuneebah Adams, Carmen de Kock, Peter J Smith, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)-H-HydroxylationAlexander Berger, Talea Knak, Anna-Lene Kiffe-Delf, et al.
ACS Infectious Diseases|March 6, 2021
Benzimidazole Derivatives Are Potent against Multiple Life Cycle Stages of <i>Plasmodium falciparum</i> Malaria ParasitesMeta Leshabane, Godwin Akpeko Dziwornu, Dina Coertzen, et al.
Journal of Medicinal Chemistry|June 12, 2018
Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of MalariaNishanth Kandepedu, Diego Gonzàlez Cabrera, Srinivas Eedubilli, et al.
Journal of Medicinal Chemistry|September 1, 2015
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidinesDiego Gonzàlez Cabrera, Frederic Douelle, Claire Le Manach, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2024
Characterization of antimalarial activity of artemisinin-based hybrid drugsHelenita Costa Quadros, Lars Herrmann, Jeanne Manaranche, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
hERG, <i>Plasmodium</i> Life Cycle, and Cross Resistance Profiling of New Azabenzimidazole Analogues of AstemizoleDickson Mambwe, Dina Coertzen, Meta Leshabane, et al.
Journal of Medicinal Chemistry|April 12, 2021
Antimalarial Benzimidazole Derivatives Incorporating Phenolic Mannich Base Side Chains Inhibit Microtubule and Hemozoin Formation: Structure-Activity Relationship and <i>In Vivo</i> Oral Efficacy StudiesGodwin Akpeko Dziwornu, Dina Coertzen, Meta Leshabane, et al.
Pageof 32